Reporting their findings in The BMJ [2] (online, 20 October 2016 ) , the team found that there was a similar level of breast cancer risk among the 498 patients who used GLP-1 analogues, such as liraglutide and exenatide, and the 2,422 patients who used DPP-4 inhibitors, at 4.4 and 3.4 per 1,000 person-years, respectively
However, some people may experience mild side effects, including: Injection site reactions (swelling, redness, discomfort) Allergic reactions manifesting with hives, rash, difficulty breathing (in very rare cases) Gastrointestinal symptoms such as nausea and vomiting Mild headache Before starting the Glutathione IV procedure, you need to complete a medical form detailing any underlying health conditions and medications you currently take
Educational and research information only
Yes, for local effects
Despite its importance, many people do not consume adequate amounts of magnesium, leading to potential deficiencies that can affect overall health